Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease

PURPOSE OF REVIEW: Patients with non-alcoholic fatty liver disease (NAFLD), often considered as the hepatic manifestation of the metabolic syndrome, represent a population at high cardiovascular risk and frequently suffer from atherogenic dyslipidemia. This article reviews the pathogenic interrelati...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Anna, Lang, Sonja, Goeser, Tobias, Demir, Münevver, Steffen, Hans-Michael, Kasper, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Statin Drugs (R. Ceska, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236990/
https://www.ncbi.nlm.nih.gov/pubmed/35507279
http://dx.doi.org/10.1007/s11883-022-01028-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236990/
https://www.ncbi.nlm.nih.gov/pubmed/35507279
http://dx.doi.org/10.1007/s11883-022-01028-4

Ejemplares similares